|
You are here: Home: BCU Nurses 2004 Vol 2 Issue 1: Faculty Affiliations and Disclosures
FACULTY AFFILIATIONS AND DISCLOSURES
Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. The presenting faculty reported the following:
| Sandra S Franco, MD |
Director of the Locally Advanced and Metastatic Breast Cancer Program Cancer Research Network Inc, Plantation, Florida Grants/Research Support: Aventis Pharmaceuticals Inc, Eli Lilly & Company, GlaxoSmithKline, Pfizer Inc,
Consultant: Aventis Pharmaceuticals Inc, Novartis Pharmaceuticals, Pfizer Inc
Honorarium: Aventis Pharmaceuticals Inc, Eli Lilly & Company |
| Cynthia Frankel, RN, OCN |
Administrative Director, Cancer Research Network Inc, C Frankel Inc
Consultant in Clinical Oncology, Research & Marketing,
Plantation, Florida
Consultant: Genentech BioOncology
Honorarium: Genentech BioOncology, Ortho Biotech Products LP,
Pfizer Inc |
| |
|
|
| OTHER SPEAKERS IN THIS PROGRAM |
|
| |
|
|
| |
Michael Baum, ChM, FRCS |
Stephen E Jones, MD |
| |
Robert Carlson, MD |
V Craig Jordan, PhD, DSc |
| |
Sharyn Carrasco, RN, MSN, OCN, FAAN |
Charles L Vogel, MD, FACP |
| |
Gabriel Hortobagyi, MD |
|
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The Postgraduate Institute for Medicine (PIM), Research To Practice and AstraZeneca Pharmaceuticals LP do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Research To Practice and AstraZeneca Pharmaceuticals LP. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
|
|
